PRJNA487207
Impact of azithromycin and allograft rejection on the post-lung transplant (LTx) microbiota
Determine if azithromycin could have beneficial effects after LTx by modulation post-LTx bronchoalveolar lavage (BAL) microbiota, if changes in BAL microbiota in the first 2 years after LTx are linked to acute and chronic rejection development and how post-LTx BAL microbiota correlates with levels of inflammatory cytokines.